CompaniesAnglian Pharmaceuticals

Anglian Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

6

As Collaborator

0

Total Enrollment

794

By Status

COMPLETED: 4TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT02840500
NCT02836379
NCT03435120
Hover over trial bars to see details

Recent Trials

NCT04742413Lead Sponsor
A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.
N/ATerminated
9 participants
Started: Dec 29, 2020 · Completed: Mar 15, 2022
NCT04485676Lead Sponsor
Dalbavancin in Real Clinical Practice in Spain
N/ACompleted
187 participants
Started: Jul 15, 2020 · Completed: Feb 21, 2021
NCT04122729Lead Sponsor
N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COS
N/AUnknown
300 participants
Started: Sep 25, 2019 · Completed: Jun 30, 2020
NCT03435120Lead Sponsor
Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)
N/ACompleted
118 participants
Started: Dec 21, 2017 · Completed: Feb 14, 2020
NCT02836379Lead Sponsor
Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent
N/ACompleted
79 participants
Started: Jul 8, 2016 · Completed: Feb 28, 2018
View all 6 trials →